The poem is called "Lechleiter's Tragic Ambition," and deals with (Lilly's) upcoming patent expiration of top-selling drug Zyprexa.
Inspired by her beauty
our great achievement stands
the largest moving object
built by management's own hand
The name we gave is fitting
and helped us to believe
"Lilly" is unsinkable
a long life she will lead
The 10th of April 2011
and "zyprexa" sails at noon
shouts of joy come from the crowd
but silence follows soon . . .
(the rest is here)
There's no way to know if this author is actually a Lilly insider. But it sure sounds like it. Anyone want to guess on this person's identity?
My money's on Ruth.
________________________________
I get a lot of rejection slips, and most of them are about the same. But sometimes I get a strange one. Like this one:
Dear Writer:
Thank you for submitting your work to (name redacted). Unfortunately we are able to use it at this time. This could be due to any number of reasons. Ideally, we would be able to write a personal letter to each writer and provide comments, but the size of our staff and volume of submissions make personal responses extremely difficult. We apologize for the excruciating delay for this response, the financial climate has forced us into spending too much extra time at budget meetings and has made unpaid volunteers and interns a rarity.
Hey, I'm the one getting rejected here. Quit yer bitching.
0 comments:
Post a Comment